发明名称 |
Desalination of a composition comprising a contrast agent |
摘要 |
The invention relates to industrial preparation of contrast agents, and further to an improved process for the purification of contrast agents. In particular, it relates to a process for reducing the salt content of compositions comprising an MR contrast agent or an X-ray contrast agent, such as a non-ionic iodinated monomeric compound or a non-ionic iodinated dimeric compound. |
申请公布号 |
US9474808(B2) |
申请公布日期 |
2016.10.25 |
申请号 |
US201113995588 |
申请日期 |
2011.12.20 |
申请人 |
GE HEALTHCARE AS |
发明人 |
Birkeland Aslaug |
分类号 |
A61K49/04;A61K49/06;C07C231/24;C07C237/46;B01D61/44;A61K49/00;B01D61/42;B01D61/58;C02F1/469 |
主分类号 |
A61K49/04 |
代理机构 |
Wood IP LLC |
代理人 |
Wood IP LLC |
主权项 |
1. A process for purifying a first composition comprising (i) a contrast agent selected from the group consisting of iohexol, iodixanol, ioforminol, and a magnetic resonance (MR) contrast agent, and (ii) at least one salt, the process comprising:
desalinating the first composition by electrodeionization (EDI), using a wafer-based EDI device, to yield a second composition including the contrast agent and a first reduced concentration of the at least one salt; performing one of purifying and desalinating the second composition using electrodialysis (ED) to yield a third composition including the contrast agent and a second reduced concentration of the at least one salt; crystallizing the third composition to yield a crystallized third composition including a crystallized contrast agent and the at least one salt; dissolving the crystallized third composition in a solvent to yield a fourth composition; and purifying the fourth composition to further reduce a concentration of the at least one salt in the fourth composition. |
地址 |
Oslo NO |